Cabaletta Bio logo

Cabaletta Bio Share Price Today

(NASDAQ: CABA)

Cabaletta Bio share price is $1.85 & ₹160.89 as on 6 Mar 2025, 2.30 'hrs' IST

$1.85

0.09

(5.11%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Cabaletta Bio share price in Dollar and Rupees. Guide to invest in Cabaletta Bio stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Cabaletta Bio, along with analyst recommendations, forecasts, and comprehensive financials.

Cabaletta Bio share price movements

  • Today's Low: $1.74
    Today's High: $1.85

    Day's Volatility :6.12%

  • 52 Weeks Low: $1.59
    52 Weeks High: $23.17

    52 Weeks Volatility :93.14%

Cabaletta Bio (CABA) Returns

PeriodCabaletta Bio IncSector (Health Care)Index (Russel 2000)
3 Months
-43.08%
3.7%
0.0%
6 Months
-59.25%
-2.8%
0.0%
1 Year
-91.8%
2.5%
0.0%
3 Years
-1.6%
12.9%
-11.6%

Cabaletta Bio (CABA) Key Statistics

in dollars & INR

Previous Close
$1.76
Open
$1.8
Today's High
$1.8534
Today's Low
$1.74
Market Capitalization
$86.0M
Today's Volume
$592.6K
52 Week High
$23.17
52 Week Low
$1.59
Revenue TTM
$0.0
EBITDA
$-112.9M
Earnings Per Share (EPS)
$-2.28
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-62.16%

How to invest in Cabaletta Bio Stock (CABA) from India?

It is very easy for Indian residents to invest directly in Cabaletta Bio from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Cabaletta Bio stock in both Indian Rupees (INR) and US Dollars (USD). Search for Cabaletta Bio or CABA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Cabaletta Bio or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Cabaletta Bio shares which would translate to 0.470 fractional shares of Cabaletta Bio as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Cabaletta Bio, in just a few clicks!

Returns in Cabaletta Bio (CABA) for Indian investors in Rupees

The Cabaletta Bio stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Cabaletta Bio investment value today

Current value as on today

₹13,149

Returns

₹86,851

(-86.85%)

Returns from Cabaletta Bio Stock

₹91,800 (-91.8%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Cabaletta Bio (CABA)

-12%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Cabaletta Bio Stock from India on INDmoney has decreased by -12% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Cabaletta Bio

  • T. Rowe Price Investment Management,Inc.

    8.34%

  • Adage Capital Partners Gp LLC

    7.44%

  • BlackRock Inc

    6.95%

  • Vanguard Group Inc

    5.87%

  • Bain Capital Life Sciences Investors, LLC

    5.65%

  • Jennison Associates LLC

    5.14%

Analyst Recommendation on Cabaletta Bio

Buy

    94%Buy

    5%Hold

    0%Sell

Based on 17 Wall street analysts offering stock ratings for Cabaletta Bio(by analysts ranked 0 to 5 stars)

Based on 17 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
16
16
14
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Cabaletta Bio Stock (CABA)

What analysts predicted

Upside of 1013.51%

Target:

$20.60

Current:

$1.85

Insights on Cabaletta Bio Stock (Ticker Symbol: CABA)

  • Price Movement

    In the last 1 month, CABA stock has moved down by -28.8%
  • CABA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 158.3%
  • CABA vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 61.4%

Cabaletta Bio Technicals Summary

Sell

Neutral

Buy

Cabaletta Bio is currently in a neutral trading position according to technical analysis indicators.

Cabaletta Bio (CABA) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Cabaletta Bio Inc logo
-20.26%
-59.25%
-91.8%
-1.6%
-85.47%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Cabaletta Bio Inc logo
NA
NA
NA
-2.23
-0.62
-0.38
NA
3.57
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Cabaletta Bio Inc logo
Buy
$86.0M
-85.47%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Cabaletta Bio

Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. The company's lead product candidate is CABA-201, a fully human anti-CD19 binder for the treatment of Phase 1/2 clinical trials in dermatomyositis, anti-synthetase syndrome, immune-mediated necrotizing myopathy, lupus nephritis, non-renal systemic lupus erythematosus, systemic sclerosis, and generalized myasthenia gravis. It also develops DSG3-CAART, which is in Phase I/II clinical trial for the treatment of mucosal pemphigus vulgaris; and MuSK-CAART, an investigational cell therapy that is in Phase I/II clinical trial for treating patients with anti- muscle-specific kinase antibody positive myasthenia gravis. It has a collaboration with the University of Pennsylvania and the Children's Hospital of Philadelphia; Nanjing IASO Biotherapeutics Co., Ltd; Oxford Biomedica; and WuXi Advanced Therapies, Inc. The company was formerly known as Tycho Therapeutics, Inc. and changed its name to Cabaletta Bio, Inc. in August 2018. Cabaletta Bio, Inc. was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania.
Organization
Cabaletta Bio
Employees
154
CEO
Dr. Steven A. Nichtberger M.D.
Industry
Health Technology

Management People of Cabaletta Bio

NameTitle
Dr. Steven A. Nichtberger M.D.
Co-Founder, Chairman, CEO & President
Dr. David J. Chang FACR, M.D., M.P.H.
Chief Medical Officer
Dr. Gwendolyn K. Binder Ph.D.
President of Science & Technology
Dr. Michael C. Milone M.D., Ph.D.
Co-Founder & Co-Chair of Scientific Advisory Board
Dr. Aimee Payne M.D., Ph.D.
Co-Founder & Co-Chair of Scientific Advisory Board
Mr. Anup Marda M.B.A.
Chief Financial Officer
Dr. Qing Sarah Yuan Ph.D.
Chief Technology Officer
Dr. Samik Basu M.D.
Chief Scientific Officer
Mr. Michael Gerard J.D.
General Counsel & Secretary
Ms. Heather Harte-Hall M.Sc.
Chief Compliance Officer

Important FAQs about investing in CABA Stock from India :

What is Cabaletta Bio share price today?

Cabaletta Bio share price today stands at $1.85, Open: $1.80 ; Previous Close: $1.76 ; High: $1.85 ; Low: $1.74 ; 52 Week High: $23.17 ; 52 Week Low: $1.59.

The stock opens at $1.80, after a previous close of $1.76. The stock reached a daily high of $1.85 and a low of $1.74, with a 52-week high of $23.17 and a 52-week low of $1.59.

Can Indians buy Cabaletta Bio shares?

Yes, Indians can invest in the Cabaletta Bio (CABA) from India.

With INDmoney, you can buy Cabaletta Bio at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Cabaletta Bio at zero transaction cost.

How can I buy Cabaletta Bio shares from India?

It is very easy to buy Cabaletta Bio from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Cabaletta Bio (CABA) be purchased?

Yes, you can buy fractional shares of Cabaletta Bio with INDmoney app.

What are the documents required to start investing in Cabaletta Bio stocks?

To start investing in Cabaletta Bio, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Cabaletta Bio Stock (CABA)?

Today’s highest price of Cabaletta Bio (CABA) is $1.85.

Today’s lowest price of Cabaletta Bio (CABA) is $1.74.

What is today's market capitalisation of Cabaletta Bio?

Today's market capitalisation of Cabaletta Bio CABA is 86.0M

What is the 52 Week High and Low Range of Cabaletta Bio Stock (CABA)?

  • 52 Week High

    $23.17

  • 52 Week Low

    $1.59

What are the historical returns of Cabaletta Bio (CABA)?

  • 1 Month Returns

    -20.26%

  • 3 Months Returns

    -59.25%

  • 1 Year Returns

    -91.8%

  • 5 Years Returns

    -85.47%

Who is the Chief Executive Officer (CEO) of Cabaletta Bio ?

Dr. Steven A. Nichtberger M.D. is the current Chief Executive Officer (CEO) of Cabaletta Bio.